Polyarteritis nodosa in Croatian children: a retrospective study over the last 20 years

Marija Jelusic1, Masa Vikic-Topic, Danica Batinic

  • 1Division of Paediatric Immunology and Rheumatology, Department of Paediatrics, University Hospital Centre Zagreb, Zagreb University School of Medicine, Kispaticeva 12, 10000, Zagreb, Croatia, marija.jelusic.drazic@gmail.com.

Rheumatology International
|December 15, 2012
PubMed

Insights

This study analyzed childhood polyarteritis nodosa (PAN) in Croatia, finding skin and joint issues common. Corticosteroids were primary treatment, with some severe cases needing immunosuppressants.

Area of Science:

  • Pediatric Rheumatology
  • Vasculitis Research
  • Rare Childhood Diseases

Background:

  • Polyarteritis nodosa (PAN) is a rare, serious vasculitis affecting children.
  • Understanding regional variations in childhood PAN is crucial for diagnosis and management.

Purpose of the Study:

  • To characterize the clinical features, treatments, and outcomes of pediatric PAN in Croatia.
  • To compare Croatian pediatric PAN cases with international data.

Main Methods:

  • A cross-sectional study of 12 children diagnosed with PAN using EULAR/PRES/PRINTO criteria over two decades.
  • Data collected on demographics, PAN classification, symptoms, inflammatory markers, autoantibodies, and treatment.

Main Results:

  • PAN accounted for 3.8% of childhood vasculitides. Systemic PAN (58%) was most common, followed by microscopic polyangiitis (25%) and cutaneous PAN (17%).
  • Key symptoms included skin involvement (90%), arthritis/arthralgia (60%), and central nervous system (CNS) involvement (33%).
  • All patients received corticosteroids; immunosuppressants were used for severe cases. Two (17%) microscopic polyangiitis patients died from renal failure.

Conclusions:

  • Croatian pediatric PAN exhibits distinct features compared to international cohorts, particularly in symptom prevalence.
  • Early diagnosis and tailored treatment, including corticosteroids and immunosuppressants, are vital for managing pediatric PAN and improving outcomes.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...